previous year 7.62%. Income from medical treatments in the separate financial statement went up 4.79% due to the increased in the number of out-patients to 2.57% but the decreased in the number of in
the total equity was 7,671.02 million baht. For the Separate financial statements, the Company had net profit of the fourth quarter of 2019 was 449.87 million baht. A decrease of 5.04 million baht or
% For the separate financial statements, the Company shows operation results for the six-month period ended June, 2017 with the following details: unit: THB million 2017 2016 Change (THB million) Change
due to increase of export sales. 2) Cost of sales decreased by Baht 10.80 million due to sales amount increase from selling price increasing. Cost of sales ratio at 87.54% (2017 : at 89.36%) which
to increase of export sales increased by Baht 10.95 million and local sales increased by Baht 1.45 million. 2) Cost of sales increase by Baht 4.38 million mainly from increase from employee benefit
million increased by Baht 19.77 million or 9.29% from the quarter 3/2017, mainly due to increase of export sales. 2) Cost of sales increased by Baht 2.98 million. The increased of cost of sales due to
20% To : President of the Stock Exchange of Thailand Attachment : Consolidated of Financial Statements & Separate Financial Statements for Year Ended 2018 Far East Fame Line DDB Public Company Limited
, mainly due to increase of export sales and local sales. 2) Cost of sales decreased by Baht 16.82 million due to sales amount increase from selling price increasing and new local customers. Cost of sales
operating performance for 31 June 2017 as the following. Key Financial Information on 31 June 2017 , 2016 (Unit : thousands) Statements of Income Separate financial statements June 31,2017 June 31,2016
operating performance for 30 September 2017 as the following. Key Financial Information on 30 September 2017 , 2016 (Unit : thousands) Statements of Income Separate financial statements 30 September 2017 30